Evidence map›Paper›PMID 31676975›Full record

ArticleJournal of neurology2020

Machine-learning-derived rules set excludes risk of Parkinson's disease in patients with olfactory or gustatory symptoms with high accuracy.

Jörn Lötsch, Antje Haehner, Thomas Hummel

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Unsupervised Clustering of Olfactory Phenotypes.American journal of rhinology & allergy · 2022
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jörn LötschInstitute of Clinical Pharmacology, Goethe-University, Theodor Stern Kai 7, 60590, Frankfurt am Main, Germany. j.loetsch@em.uni-frankfurt.de.ORCID http://orcid.org/0000-0002-5818-6958
Antje HaehnerDepartment of Otorhinolaryngology, Smell and Taste Clinic, TU Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
Thomas HummelDepartment of Otorhinolaryngology, Smell and Taste Clinic, TU Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
Technische Universität Dresden · DEGoethe University Frankfurt · DE

Funding

Deutsche Forschungsgemeinschaft HU 441/18Landesoffensive zur Entwicklung wissenschaftlich - ökonomischer Exzellenz (LOEWE) LOEWE-Zentrum für Translationale Medizin und Pharmakologie
6 · The paper itself

Abstract

backgroundChemosensory loss is a symptom of Parkinson's disease starting already at preclinical stages. Their appearance without an identifiable etiology therefore indicates a possible early symptom of Parkinson's disease. Supervised machine-learning was used to identify parameters that predict Parkinson's disease among patients having sought medical advice for chemosensory symptoms.

methodsOlfactory, gustatory and demographic parameters were analyzed in 247 patients who had reported for chemosensory symptoms. Unsupervised machine-learning, implanted as so-called fast and frugal decision trees, was applied to map these parameters to a diagnosis of Parkinson's disease queried for in median 9 years after the first interview.

resultsA symbolic hierarchical decision rule-based classifier was created that comprised d = 5 parameters, including scores in tests of odor discrimination, odor identification and olfactory thresholds, the age at which the chemosensory loss has been noticed, and a familial history of Parkinson's disease. The rule set provided a cross-validated negative predictive performance of Parkinson's disease of 94.1%; however, its balanced accuracy to predict the disease was only 58.9% while robustly above guessing.

conclusionsApplying machine-learning techniques, a classifier was developed that took the shape of a set of six hierarchical rules with binary decisions about olfaction-related features or a familial burden of Parkinson's disease. Its main clinical strength lies in the exclusion of the possibility of developing Parkinson's disease in a patient with olfactory or gustatory loss.

Indexed as

Machine LearningAdolescentAdultAgedAged, 80 and overAge of OnsetCase-Control StudiesFemaleHumansMaleMiddle AgedOlfaction DisordersParkinson DiseaseProspective StudiesReproducibility of ResultsRiskData scienceDecision treesMachine-learningOlfactionParkinson’s disease

Identifiers

PMID31676975
OpenAlexW2987409750

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.